会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • MODULATORS OF THE GPR119 RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO
    • GPR119受体的调节剂和与之相关的疾病的治疗
    • US20140051629A1
    • 2014-02-20
    • US13825601
    • 2011-09-21
    • Robert M. JonesJuerg LehmannWeichao ChenJeffrey EdwardsGlen MarquezMichael E. MorganAbu J.M. SadequeSun Hee Kim
    • Robert M. JonesJuerg LehmannWeichao ChenJeffrey EdwardsGlen MarquezMichael E. MorganAbu J.M. SadequeSun Hee Kim
    • C07D413/14A61K45/06A61K31/506
    • C07D413/14A61K31/506A61K45/06
    • The present invention relates to the GPR119 receptor agonists: 3-fluoro-4-(5-fluoro-6-(4-(3-(2-fluoropropan-2-yl)-1,2,4-oxadiazol-5-yl)piperidin-1-yl)pyrimidin-4-ylamino)-N,N-dimethylbenzamide; -fluoro-4-(5-fluoro-6-(4-(3-(2-fluoro-propan-2-yl)-1,2,4-oxadiazol-5-yl)piperidin-1-yl)pyrimidin-4-ylamino)-N-methylbenzamide; and 3-fluoro-4-(5-fluoro-6-(4-(3-(2-fluoropropan-2-yl)-1,2,4-oxadiazol-5-yl)piperidin-1-yl)pyrimidin-4-ylamino)benzamide, and pharmaceutically acceptable salts, solvates, and hydrates thereof, that are useful as a single pharmaceutical agent or in combination with one or more additional pharmaceutical agents, such as, a DPP-IV inhibitor, a biguanide, an alpha-glucosidase inhibitor, an insulin analogue, a sulfonylurea, an SGLT2 inhibitor, a meglitinide, a thiazolidinedione, or an anti-diabetic peptide analogue, in the treatment of for example, a disorder selected from: a GPR119-receptor-related disorder; a condition ameliorated by increasing secretion of an incretin; a condition ameliorated by increasing a blood incretin level; a condition characterized by low bone mass; a neurological disorder; a metabolic-related disorder; type 2 diabetes; obesity; and complications related thereto.
    • 本发明涉及GPR119受体激动剂:3-氟-4-(5-氟-6-(4-(3-(2-氟丙-2-基)-1,2,4-恶二唑-5-基 )哌啶-1-基)嘧啶-4-基氨基)-N,N-二甲基苯甲酰胺; - 氟-4-(5-氟-6-(4-(3-(2-氟 - 丙-2-基)-1,2,4-恶二唑-5-基)哌啶-1-基) 吡啶-4-基氨基)-N-甲基苯甲酰胺; 和3-氟-4-(5-氟-6-(4-(3-(2-氟丙-2-基)-1,2,4-恶二唑-5-基)哌啶-1-基) 4-氨基)苯甲酰胺及其药学上可接受的盐,溶剂合物和水合物,其可用作单一药剂或与一种或多种另外的药剂如DPP-IV抑制剂,双胍类,α 葡萄糖苷酶抑制剂,胰岛素类似物,磺酰脲类,SGLT2抑制剂,氯噻嗪,噻唑烷二酮或抗糖尿病肽类似物,用于治疗例如选自以下的病症:GPR119-受体相关病症; 通过增加肠降血糖素的分泌而改善的状况; 通过增加血液肠降血糖水平来改善病情; 以低骨量为特征的病症; 神经障碍 代谢相关疾病; 2型糖尿病; 肥胖; 和相关的并发症。